This trial is active and currently recruiting.
Who Can Participate
Children ages 4 and older and adults who have been diagnosed with asthma for at least 1 year, who are on daily asthma inhalers and have had at least 1 asthma flare in the last 12 months.
Age: 4+ Gender: Any Gender
Estimated Time Commitment
After screening, treatment will last from 24 to 36 weeks